These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24151802)

  • 21. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
    Sasayama D; Hiraishi A; Tatsumi M; Kamijima K; Ikeda M; Umene-Nakano W; Yoshimura R; Nakamura J; Iwata N; Kunugi H
    Pharmacogenomics J; 2013 Aug; 13(4):354-8. PubMed ID: 22584459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
    Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
    Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging drugs for major depressive disorder.
    Connolly KR; Thase ME
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent molecular genetic studies and methodological issues in suicide research.
    Tsai SJ; Hong CJ; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):809-17. PubMed ID: 20977922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
    Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
    Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic studies of drug response and side effects in the STAR*D study, part 1.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.
    Domschke K; Hohoff C; Mortensen LS; Roehrs T; Deckert J; Arolt V; Baune BT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):224-8. PubMed ID: 17884271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
    Chi MH; Chang HH; Lee SY; Lee IH; Gean PW; Yang YK; Lu RB; Chen PS
    J Affect Disord; 2010 Nov; 126(3):430-5. PubMed ID: 20674983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review.
    Minelli A; Barlati S; Baune BT;
    Eur Neuropsychopharmacol; 2022 Jun; 59():68-81. PubMed ID: 35561539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Tsai SJ; Hong CJ; Liou YJ
    Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
    Spronk D; Arns M; Barnett KJ; Cooper NJ; Gordon E
    J Affect Disord; 2011 Jan; 128(1-2):41-8. PubMed ID: 20619899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of unipolar major depressive disorder.
    Goltser-Dubner T; Galili-Weisstub E; Segman RH
    Isr J Psychiatry Relat Sci; 2010; 47(1):72-82. PubMed ID: 20686202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy.
    Lin E; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():334-40. PubMed ID: 25708651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
    Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.
    Fabbri C; Hosak L; Mössner R; Giegling I; Mandelli L; Bellivier F; Claes S; Collier DA; Corrales A; Delisi LE; Gallo C; Gill M; Kennedy JL; Leboyer M; Lisoway A; Maier W; Marquez M; Massat I; Mors O; Muglia P; Nöthen MM; O'Donovan MC; Ospina-Duque J; Propping P; Shi Y; St Clair D; Thibaut F; Cichon S; Mendlewicz J; Rujescu D; Serretti A
    World J Biol Psychiatry; 2017 Feb; 18(1):5-28. PubMed ID: 27603714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.